Compliance Insight podcast Series

The optimization of processes for the development and manufacture of biopharmaceuticals is pivotal for producing quality products.

This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.

CDMOs who have integrated technologies can help further the advancement of ADC development.

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

The company is recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches because of possible multi-stacking of patches.

Another eight medications already authorized in the EU were recommended for extensions of various indications.